Literature DB >> 23522205

Non-small cell lung cancer stage IV long-term survival with isolated spleen metastasis.

Rodrigo A S Sardenberg1, Clovis Pinto, Cynthia A Bueno, Riad N Younes.   

Abstract

Splenic metastasis is rare and generally associated with disseminated disease, often seen in breast cancer, colorectal and ovarian carcinoma, and melanoma. Isolated metastasis to the spleen is rare, with only 93 cases from all sources having been reported up to 2007. Moreover, isolated splenic metastasis from primary lung cancer is extremely rare, with only 11 cases reported to date. We report a case of isolated splenic metastasis in a woman 8 months after lobectomy for an adenocarcinoma in the right lung completely resected. After 8 years of follow-up, the patient is still alive with no evidence of metastatic recurrence.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23522205     DOI: 10.1016/j.athoracsur.2012.08.086

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  15 in total

1.  Splenic oligometastasis: Report of a patient successfully treated with stereotactic body radiation therapy.

Authors:  Aditya Juloori; Shireen Parsai; Kevin Stephans
Journal:  J Radiosurg SBRT       Date:  2019

2.  Isolated spleen recurrence in a patient with lung adenocarcinoma: A case report.

Authors:  Kesato Iguchi; Osamu Ishibashi; Tadashi Kondo; Katsunori Kagohashi; Norio Takayashiki; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2015-05-27       Impact factor: 2.447

Review 3.  Surgical approach in oligometastatic non-small cell lung cancer.

Authors:  Davide Patrini; Nikolaos Panagiotopoulos; Benedetta Bedetti; Sofoklis Mitsos; Roberto Crisci; Piergiorgio Solli; Luca Bertolaccini; Marco Scarci
Journal:  Ann Transl Med       Date:  2018-03

4.  The Rarity of Metastasis to the Spleen - a Phenomenon with an Unknown Mechanism.

Authors:  E S Andryukhova; L A Tashireva; A V Isaeva; S V Vtorushin; M V Zavyalova; V M Perelmuter
Journal:  Bull Exp Biol Med       Date:  2022-10-10       Impact factor: 0.737

Review 5.  Surgical management of oligometastatic non-small cell lung cancer.

Authors:  Nuria M Novoa; Gonzalo Varela; Marcelo F Jiménez
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Abdominal pain as initial presentation of lung cancer.

Authors:  Naseem Eisa; Bishr Alhafez; Abdul Hamid Alraiyes; M Chadi Alraies
Journal:  BMJ Case Rep       Date:  2014-05-16

7.  Endometrial metastasis of lung adenocarcinoma: a report of two cases.

Authors:  Zeeshan Ahmad; Ahmad Raza; Manish R Patel
Journal:  Am J Case Rep       Date:  2015-05-18

8.  TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.

Authors:  Lingyi Fu; Ke Shi; Jingshu Wang; Wangbing Chen; Dingbo Shi; Yun Tian; Wei Guo; Wendan Yu; Xiangsheng Xiao; Tiebang Kang; Shusen Wang; Wenlin Huang; Wuguo Deng
Journal:  Mol Cancer       Date:  2014-04-26       Impact factor: 27.401

9.  Splenectomy for isolated splenic metastasis from primary lung adenocarcinoma.

Authors:  Marc C Grant-Freemantle; Gary A Bass; Waqas T Butt; Amy E Gillis
Journal:  BMJ Case Rep       Date:  2020-03-08

10.  Isolated Splenic Metastasis from Non-Small-Cell Lung Cancer: A Case Report and Review of the Literature.

Authors:  Nikolaos Mitsimponas; Maria Mitsogianni; Felipe Crespo; Karl-Axel Hartmann; Stefan Diederich; Bernd Klosterhalfen; Aristoteles Giagounidis
Journal:  Case Rep Oncol       Date:  2017-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.